Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Karli_40
    Junior Member
    • Dec 2014
    • 6

    Questions on Cuffdiff with mapping to transcriptome

    Hi Everyone,

    I have some questions on if my results are valid by using cuffdiff.
    What I did currently is that I did alignment with bowtie to drosophila transcript-r5.55. Unlike common references, this reference is in the format of following:
    >FBtr0086024 type=mRNA; loc=2R:complement(1944862..1947063); ID=FBtr0086024; name=CG7856-RA; dbxref=FlyBase:FBtr0086024,FlyBase_Annotation_IDs:CG7856-RA,REFSEQ:NM_136354; score=11; score_text=Strongly Supported; MD5=7ca9c4371b97aaf7046cf83fefb65eb8; length=2202; parent=FBgn0033056; release=r5.55; species=Dmel;
    GGTAAAGTTGCCTTGGCGTCAGTTGGCAGTTTGGGAAAAGCCTACACACT
    TAATATTTCGATAGATACACTTATTTCGCAATCGTAGAAGATACCACAAA
    TCTCTCTTCCGTAAATTATAAGTATGTCCAAGAGGGTGAGCATCATGTTG
    CCCGACGAAATACCTGCGGCTCCGTCAGGCAGCAGGAGGAACCCGATGCC......
    So when I got the bam file, the column usually indicating chromosome localization is already filled with FBtr#:XXX-XXX (instead of chr1:XXX-XXX) which could be used as annotation.
    I run the bam file in cufflinks to get the GTF file for each file and run cuffmerge to get a merged GTF file for files in the same set of experiment. Then I run cuffdiff with merged GTF file and bam files. I did NOT use any reference GTF files during those steps since the reference for mapping I used is already annotated as I described above. In cuffdiff output file isoform_exp.diff under the column of loci, the value also remained FBtr#:XXX-XXX. It means for each transcript, it is compared in different region. So should I consider if any of the region is differentially expressed, the transcript is differentially expressed? And is this going to affect validity of cuffdiff's calculation since this equals to do assembly first then quantification for differential expression compared to usually it does quantification first then assembly?

    Thanks in advance.

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    Yesterday, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:10 AM
0 responses
8 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-08-2026, 10:08 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Working...